Dr. David G. Alonzo Reaches 1,000th da Vinci Robotic-Assisted Cancer Surgery Milestone

Translate to Spanish or other 102 languages!

DHR Health Urologic Oncologist, Dr. David G. Alonzo, has successfully performed his 1,000th da Vinci robotic-assisted surgical procedure for the treatment of urologic cancers. Courtesy image. Bgd for illustration purposes
DHR Health Urologic Oncologist, Dr. David G. Alonzo, has successfully performed his 1,000th da Vinci robotic-assisted surgical procedure for the treatment of urologic cancers. Courtesy image. Bgd for illustration purposes
- Advertisement -

EDINBURG, Texas – DHR Health Urologic Oncologist, Dr. David G. Alonzo, has successfully performed his 1,000th da Vinci robotic-assisted surgical procedure for the treatment of urologic cancers. This significant milestone highlights Alonzo’s extensive expertise in advanced, minimally invasive urological surgery and reinforces DHR Health’s commitment to providing cutting-edge cancer care to patients of the Rio Grande Valley.

Da Vinci robotic-assisted surgery offers enhanced precision, visualization, and dexterity allowing surgeons to perform complex procedures through small incisions. The result is typically less pain, reduced blood loss, shorter hospital stays, and a faster return to normal activities for patients. Alonzo’s high volume of robotic procedures includes radical prostatectomies, partial nephrectomies, and other complex urological surgeries.

“Reaching 1,000 robotic surgeries is a testament to the benefits of this technology and the dedication of our entire surgical team,” said Alonzo. “It’s incredibly rewarding to see our patients recover more quickly and with better outcomes, and I look forward to continuing to provide this advanced care.”

- Advertisement -

Born and raised in the Rio Grande Valley, Alonzo earned his undergraduate degree from the University of Texas – Pan American. He received his medical degree from Baylor College of Medicine in Houston, Texas. He completed his internship in general surgery and residency in urology at Jackson Memorial Hospital in Miami, Florida. He continued his training with a fellowship in surgical urologic oncology at the University of Miami.

As a fellowship-trained surgeon, Alonzo has expertise in the treatment of urologic cancers and specializes in robotic surgery for prostate, penile, bladder, and kidney cancer. This milestone not only marks a professional achievement for Alonzo but also reflects DHR Health’s dedication to improving patient outcomes through advanced technology and innovative surgical care. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.
- Advertisement -